A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia
NCT06016556
·
clinicaltrials.gov ↗
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Covid-19
Interventions
DRUG:
nirmatrelvir, ritonavir
Sponsor
Pfizer